Beck Bode LLC’s Rockwell Medical RMTI Stock Holding History

Beck Bode LLC’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3	Closed	–	–	259
2021 Q2	$0	Buy	+3	New	+$310	﹤0.01%	326
2020 Q4	–	Sell	-3	Closed	–	–	222
2020 Q3	$0	Buy	+3	New	+$519	﹤0.01%	320

Other funds holding RMTI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

VCA

Verdence Capital Advisors Hunt Valley, Maryland $1.9B AUM 36.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

SkyOak Wealth Southfield, Michigan $612M AUM 23.73% 1-Year Est. Return

Beck Bode LLC's RMTI Position: Q3 2021 in Review

Beck Bode LLC sold out of Rockwell Medical (RMTI) in Q3 2021, closing a stake of 3 shares.

Beck Bode LLC first reported a position in RMTI in Q3 2020 and held it in 2 quarters. The position peaked at $0 in Q2 2021. 62 funds tracked by Wall St. Rank hold RMTI as of Q3 2021.

Beck Bode LLC reported no remaining Rockwell Medical position as of Q3 2021 after selling out during the quarter.
Beck Bode LLC sold 3 Rockwell Medical shares in Q3 2021.
Beck Bode LLC first reported a position in Rockwell Medical in Q3 2020 and held it in 2 quarters.
Beck Bode LLC's Rockwell Medical position peaked at $0 in Q2 2021.
62 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2021.

Based on Beck Bode LLC's 13F filing for Q3 2021, filed 22 Oct 2021.